S
WST icon

Sachetta’s West Pharmaceutical WST Stock Holding History

Sachetta’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8
Closed -$2.01K – 1227
2026
Q1 		$2.01K Sell
8
-14
-64% -$3.48K ﹤0.01% 897
2025
Q4 		$6.05K Hold
22
– – ﹤0.01% 500
2025
Q3 		$5.77K Buy
22
+9
+69% +$2.19K ﹤0.01% 569
2025
Q2 		$2.85K Buy
13
+10
+333% +$2.14K ﹤0.01% 724
2025
Q1 		$672 Sell
3
-10
-77% -$2.76K ﹤0.01% 990
2024
Q4 		$4.26K Buy
13
+7
+117% +$2.2K ﹤0.01% 626
2024
Q3 		$1.8K Buy
6
+2
+50% +$612 ﹤0.01% 905
2024
Q2 		$1.2K Buy
4
+1
+33% +$353 ﹤0.01% 1001
2024
Q1 		$1.06K Hold
3
– – ﹤0.01% 897
2023
Q4 		$1.06K Buy
+3
New +$1.06K ﹤0.01% 897

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Sachetta's WST Position: Q2 2026 in Review

Sachetta sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 8 shares — an estimated $2.01K sold.

Sachetta first reported a position in WST in Q4 2023 and held it in 10 quarters. The position peaked at $6.05K in Q4 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Sachetta reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Sachetta sold 8 West Pharmaceutical shares in Q2 2026, an estimated $2.01K.
  • Sachetta first reported a position in West Pharmaceutical in Q4 2023 and held it in 10 quarters.
  • Sachetta's West Pharmaceutical position peaked at $6.05K in Q4 2025.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.